Our study revealed that withaferin A acts as a potent molecular ligand for LXR-α in HCC and inhibits NF-κB target genes (Shiragannavar et al., 2021; Shiragannavar et al., 2022). The gene discussed is NR1H3; the disease is hepatocellular carcinoma.